Showing results (201-210 of 221) with videos related to
Sort By:
Pageof 23
Nature Communications|April 28, 2026
Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trialsYiming Li, Cenfu Wei, Wenjing Yang, et al.Lancet (London, England)|June 12, 2022
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trialBruce E Sands, Peter M Irving, Timothy Hoops, et al.The Journal of Clinical Investigation|February 8, 2024
Tissue-specific reprogramming leads to angiogenic neutrophil specialization and tumor vascularization in colorectal cancerTriet M Bui, Lenore K Yalom, Edward Ning, et al.Inflammatory Bowel Diseases|August 29, 2009
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitisDaniel C Baumgart, Stephan R Targan, Axel U Dignass, et al.Journal for Immunotherapy of Cancer|November 14, 2024
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse eventsMalek Shatila, Hao Chi Zhang, Anusha Shirwaikar Thomas, et al.The American Journal of Gastroenterology|April 13, 2022
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness PanelParambir S Dulai, Victoria Rai, Laura E Raffals, et al.Journal of Crohn'S & Colitis|May 10, 2015
The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS]Simon P L Travis, Dan Schnell, Brian G Feagan, et al.Inflammatory Bowel Diseases|April 29, 2025
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC StudiesStefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, et al.Gastroenterology|July 30, 2013
Reliability and initial validation of the ulcerative colitis endoscopic index of severitySimon P L Travis, Dan Schnell, Piotr Krzeski, et al.Gut|October 15, 2011
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Simon P L Travis, Dan Schnell, Piotr Krzeski, et al.Pageof 23